NewAmsterdam Pharma Co N.V.

NAMS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001936258

SEC filings (opens in a new tab)

In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 4 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.

Other share classesNAMSW

Q1 2025 vs. Q4 2024

How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of NAMS: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Q1 2025	Change
Holders	131	126	−5
Shares	98.6M	111.2M	+12.6M (+12.7%)
Value	$2.53B	$2.28B	−$255.7M (−10.1%)

New holders (26)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to NAMS in Q1 2025
Institution	Shares	Value	% of portfolio
Franklin Resources Inc	255,912	$5.24M	0.00%
First Trust Advisors LP	119,052	$2.44M	0.00%
StemPoint Capital LP	104,585	$2.14M	0.68%
Ameriprise Financial Inc	95,154	$1.95M	0.00%
Trexquant Investment LP	66,102	$1.35M	0.02%
ExodusPoint Capital Management, LP	59,644	$1.22M	0.02%
BVF Inc	59,065	$1.21M	0.05%
Verition Fund Management LLC	50,472	$1.03M	0.01%
HRT Financial LP	32,642	$668.0K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	29,779	$609.6K	0.00%
Bryce Point Capital, LLC	19,653	$438.1K	0.33%
Arizona State Retirement System	10,486	$214.6K	0.00%
Virtus Investment Advisers, Inc.	6,543	$133.9K	0.04%
SG Americas Securities, LLC	5,659	$116.0K	0.00%
Avanza Fonder AB	6,205	$113.0K	0.00%
Kiker Wealth Management, LLC	2,000	$40.9K	0.03%
Quarry LP	1,200	$24.6K	0.01%
Stone House Investment Management, LLC	325	$6.65K	0.00%
Continuum Advisory, LLC	154	$3.15K	0.00%
Roxbury Financial LLC	69	$1.45K	0.00%
Lindbrook Capital, LLC	45	$921	0.00%
Coldstream Capital Management Inc	24	$492	0.00%
GAMMA Investing LLC	7	$143	0.00%
SBI Securities Co., Ltd.	3	$61	0.00%
EverSource Wealth Advisors, LLC	2	$41	0.00%
True Wealth Design, LLC	2	$41	0.00%

Sold out (31)

Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of NAMS in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Opaleye Management Inc.	325,000	$8.35M
Marshall Wace, LLP	288,446	$7.41M
GMT Capital Corp	285,136	$7.33M
Maven Securities LTD	150,000	$3.85M
Ovata Capital Management Ltd	150,000	$3.85M
Alyeska Investment Group, L.P.	114,707	$2.95M
Moody Aldrich Partners LLC	79,145	$2.03M
Two Sigma Advisers, LP	74,300	$1.91M
Artia Global Partners LP	54,285	$1.40M
Tudor Investment Corp Et Al	52,208	$1.34M
Acuta Capital Partners, LLC	50,000	$1.28M
Monashee Investment Management LLC	50,000	$1.28M
Crestline Management, LP	35,068	$901.2K
Arrowstreet Capital, Limited Partnership	30,504	$784.0K
Pamalican Asset Management Ltd	30,000	$771.0K
Lazard Asset Management LLC	28,517	$732.0K
Voloridge Investment Management, LLC	28,041	$720.7K
M&T Bank Corp	27,328	$702.2K
Jump Financial, LLC	25,401	$652.8K
Teacher Retirement System of Texas	10,753	$276.0K
Walleye Capital LLC	10,506	$270.0K
Glenmede Trust Co NA	9,965	$256.1K
Cinctive Capital Management LP	9,516	$244.6K
Envestnet Asset Management Inc	9,359	$240.5K
SEI Investments Co	9,326	$239.7K
Kennedy Capital Management, Inc.	7,945	$204.2K
Virtus ETF Advisers LLC	2,834	$72.8K
Group One Trading, L.P.	176	$4.52K
Advisor Group Holdings, Inc.	142	$3.65K
Assetmark, Inc	96	$2.47K
Sandy Spring Bank	0	$6